Electrographic Flow mapping with Ablamap is a novel technique to create full temporospatial visualizations of organized action potential flow within chaotic conduction of Atrial Fibrillation. Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).
Electrographic Flow mapping can guide ablation therapy
Ablamap reveals action potential flow
Electrographic Flow helps understand Atrial Fibrillation
Phenomena revealed by Electrographic Flow Mapping. Thus far, we have identified at least three distinct AF phenotypes or patterns of EGF flow related to the initiation and maintenance of AF.
Ablacon in the news
- Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
- Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company
- Forbes lists Ablacon “25 Top Machine Learning Startups To Watch In 2019”
- Ablacon, Inc. Raises $21.5M Series A to Advance AI-Enabled Atrial Fibrillation Mapping System